4 European Projects Found
Searched on 125080 European Projects
FINISHED
European Gram Negative Antibacterial Engine (ENABLE)
Start date: Feb 1, 2014, End date: Jan 31, 2020,
...nce. Despite the recognized need for new antimicrobials for clinical use, the reality is that only two new classes of antibiotics have been brought to market in the last 30 years and many drug developers have left the field. This urgency is especially true when considering resistant Gram-negative infections where carbapenem-resistance is rising and use of drugs of last resort, such as colistin, ...
Read Project
42
Partners Participants
FINISHED
Synaptic Systems: dissecting brain function in health and disease (SYNSYS)
Start date: Jul 1, 2010, End date: Dec 31, 2014,
...ying signalling complexes pose a significant challenge to dissecting the molecular mechanisms of disease and to design efficient drugs. SynSys assembles leading European laboratories to provide the expertise and established research platforms that uniquely enable a systems-level analysis of synaptic signalling. The consortium features a closed loop from data integration and modelling, human geneti ...
Read Project
19
Partners Participants
FINISHED
BrainTrain: Integrative neuroscience school on brain function and disease (BrainTrain)
Start date: Nov 1, 2009, End date: Oct 31, 2013,
Brain disorders, in particular neurodegenerative diseases and mental illnesses are among the most prevalent and debilitating diseases. Because they are chronic, quality of life and socio-economic prospects are dramatically impaired. Increased life expectancy further enhances the impact of brain dysfunction on society. In coming decades this burden will grow into one of most pressing and costly pro ...
Read Project
14
Partners Participants
FINISHED
Combating influenza using a novel drug strategy (FluDrugStrategy)
Start date: Mar 1, 2008, End date: Aug 31, 2010,
...ombines knowledge based design and synthesis of compounds with unique patented image analysis and mathematical algorithm software to find and develop new types of potential antiviral molecules. The expertise and methodology allows for rapid discovery of lead molecules with the potential to provide new classes of drugs/vaccines which are less sensitive to viral mutation or reassortment. Work plan: ...
Read Project
